Macerich shares crossed above the average analyst 12-month target of $21.27, recently trading at $21.42 per share. The article highlights a valuation/price-target inflection point rather than a fundamental change in operating performance. Market impact is likely limited, but the stock may react to how analysts respond now that the target has been reached.
Macerich shares crossed above the average analyst 12-month target of $21.27, recently trading at $21.42 per share. The article highlights a valuation/price-target inflection point rather than a fundamental change in operating performance. Market impact is likely limited, but the stock may react to how analysts respond now that the target has been reached.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.05